Vanguard Group
CAH icon

Vanguard Group’s Cardinal Health CAH Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.14B Sell
30,575,816
-163,979
-0.5% -$27.5M 0.08% 228
2025
Q1
$4.24B Sell
30,739,795
-32,444
-0.1% -$4.47M 0.08% 259
2024
Q4
$3.64B Sell
30,772,239
-20,738
-0.1% -$2.45M 0.06% 298
2024
Q3
$3.4B Buy
30,792,977
+175,103
+0.6% +$19.4M 0.06% 315
2024
Q2
$3.01B Sell
30,617,874
-2,405
-0% -$236K 0.06% 325
2024
Q1
$3.43B Sell
30,620,279
-645,761
-2% -$72.3M 0.07% 298
2023
Q4
$3.15B Sell
31,266,040
-825,805
-3% -$83.2M 0.07% 301
2023
Q3
$2.79B Sell
32,091,845
-711,879
-2% -$61.8M 0.07% 296
2023
Q2
$3.1B Buy
32,803,724
+61,275
+0.2% +$5.79M 0.07% 284
2023
Q1
$2.47B Buy
32,742,449
+1,422,245
+5% +$107M 0.06% 341
2022
Q4
$2.41B Sell
31,320,204
-831,365
-3% -$63.9M 0.07% 328
2022
Q3
$2.14B Sell
32,151,569
-1,452,788
-4% -$96.9M 0.06% 338
2022
Q2
$1.76B Sell
33,604,357
-131,543
-0.4% -$6.88M 0.05% 403
2022
Q1
$1.91B Sell
33,735,900
-2,105,718
-6% -$119M 0.05% 435
2021
Q4
$1.85B Sell
35,841,618
-1,052,283
-3% -$54.2M 0.04% 460
2021
Q3
$1.82B Buy
36,893,901
+1,151,050
+3% +$56.9M 0.05% 450
2021
Q2
$2.04B Sell
35,742,851
-365,777
-1% -$20.9M 0.05% 413
2021
Q1
$2.19B Buy
36,108,628
+398,193
+1% +$24.2M 0.06% 359
2020
Q4
$1.91B Sell
35,710,435
-146,014
-0.4% -$7.82M 0.06% 372
2020
Q3
$1.68B Sell
35,856,449
-350,230
-1% -$16.4M 0.06% 360
2020
Q2
$1.89B Sell
36,206,679
-395,502
-1% -$20.6M 0.07% 312
2020
Q1
$1.75B Buy
36,602,181
+974,953
+3% +$46.7M 0.07% 264
2019
Q4
$1.8B Sell
35,627,228
-860,513
-2% -$43.5M 0.06% 351
2019
Q3
$1.72B Buy
36,487,741
+687,051
+2% +$32.4M 0.06% 337
2019
Q2
$1.69B Buy
35,800,690
+622,563
+2% +$29.3M 0.06% 340
2019
Q1
$1.69B Buy
35,178,127
+6,245,904
+22% +$301M 0.07% 318
2018
Q4
$1.29B Buy
28,932,223
+910,273
+3% +$40.6M 0.06% 363
2018
Q3
$1.51B Buy
28,021,950
+5,058,369
+22% +$273M 0.06% 374
2018
Q2
$1.12B Buy
22,963,581
+1,137,213
+5% +$55.5M 0.05% 452
2018
Q1
$1.37B Sell
21,826,368
-2,411,585
-10% -$151M 0.06% 378
2017
Q4
$1.49B Buy
24,237,953
+173,280
+0.7% +$10.6M 0.06% 345
2017
Q3
$1.61B Buy
24,064,673
+422,396
+2% +$28.3M 0.08% 292
2017
Q2
$1.84B Buy
23,642,277
+440,967
+2% +$34.4M 0.09% 237
2017
Q1
$1.89B Buy
23,201,310
+843,212
+4% +$68.8M 0.1% 216
2016
Q4
$1.61B Buy
22,358,098
+419,863
+2% +$30.2M 0.09% 236
2016
Q3
$1.7B Sell
21,938,235
-5,362
-0% -$417K 0.1% 209
2016
Q2
$1.71B Buy
21,943,597
+3,022
+0% +$236K 0.11% 198
2016
Q1
$1.8B Buy
21,940,575
+869,675
+4% +$71.3M 0.12% 169
2015
Q4
$1.88B Buy
21,070,900
+474,654
+2% +$42.4M 0.13% 151
2015
Q3
$1.58B Buy
20,596,246
+112,579
+0.5% +$8.65M 0.11% 169
2015
Q2
$1.71B Buy
20,483,667
+149,705
+0.7% +$12.5M 0.12% 169
2015
Q1
$1.84B Buy
20,333,962
+60,199
+0.3% +$5.43M 0.12% 161
2014
Q4
$1.64B Buy
20,273,763
+298,177
+1% +$24.1M 0.12% 170
2014
Q3
$1.5B Buy
19,975,586
+336,608
+2% +$25.2M 0.12% 169
2014
Q2
$1.35B Buy
19,638,978
+318,650
+2% +$21.8M 0.11% 195
2014
Q1
$1.35B Buy
19,320,328
+368,626
+2% +$25.8M 0.11% 174
2013
Q4
$1.27B Buy
18,951,702
+738,438
+4% +$49.3M 0.11% 175
2013
Q3
$950M Buy
18,213,264
+325,818
+2% +$17M 0.09% 228
2013
Q2
$844M Buy
+17,887,446
New +$844M 0.09% 232